×
About 41,734 results

ALLMedicine™ Bladder Cancer Center

Research & Reviews  19,755 results

ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update.
https://doi.org/10.1016/j.jacr.2021.02.011
Journal of the American College of Radiology : JACR; , Allen BC et. al.

May 7th, 2021 - Urothelial cancer is the second most common cancer, and cause of cancer death, related to the genitourinary tract. The goals of surveillance imaging after the treatment of urothelial cancer of the urinary bladder are to detect new or previously un...

The Epidemiology of Bladder Cancer.
https://doi.org/10.1016/j.hoc.2021.02.001
Hematology/oncology Clinics of North America; Mossanen M

May 7th, 2021 - There are many risk factors for bladder cancer. During an initial assessment of a patient with bladder cancer, a careful discussion and history assessment is important. Particular focus should include social history with details regarding occupati...

Molecular Biology of Bladder Cancer: Potential Implications for Therapy.
https://doi.org/10.1016/j.hoc.2021.02.009
Hematology/oncology Clinics of North America; McConkey DJ

May 7th, 2021 - Recently completed studies provided high-resolution descriptions of the molecular biological characteristics of urothelial bladder cancers. Whole transcriptome messenger RNA expression profiling revealed that they can be grouped into basal and lum...

Current Perioperative Therapy for Muscle Invasive Bladder Cancer.
https://doi.org/10.1016/j.hoc.2021.02.002
Hematology/oncology Clinics of North America; Ma J, Black PC

May 7th, 2021 - Radical cystectomy is curative in only approximately 50% of patients with muscle-invasive bladder cancer. Although perioperative radiotherapy has been tested with the intent of improving locoregional disease control, there currently is no role for...

Current Therapy and Emerging Intravesical Agents to Treat Non-Muscle Invasive Bladder C...
https://doi.org/10.1016/j.hoc.2021.02.003
Hematology/oncology Clinics of North America; Bree KK, Brooks NA et. al.

May 7th, 2021 - Transurethral resection of bladder tumor remains the cornerstone of non-muscle invasive bladder cancer management, proper risk stratification, and appropriate selection of adjuvant therapy. A single, postoperative dose of intravesical chemotherapy...

see more →

Guidelines  117 results

ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update.
https://doi.org/10.1016/j.jacr.2021.02.011
Journal of the American College of Radiology : JACR; , Allen BC et. al.

May 7th, 2021 - Urothelial cancer is the second most common cancer, and cause of cancer death, related to the genitourinary tract. The goals of surveillance imaging after the treatment of urothelial cancer of the urinary bladder are to detect new or previously un...

Moving on up: Maintenance therapy extends OS in bladder cancer
https://www.mdedge.com/hematology-oncology/article/222994/genitourinary-cancer/moving-maintenance-therapy-extends-os

May 27th, 2020 - Is maintenance therapy with an immune checkpoint inhibitor a good idea for patients with advanced bladder cancer who do not progress after initial chemotherapy?

New First-Line Standard in Metastatic Bladder Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86731

May 27th, 2020 - Maintenance therapy with a PD-L1 immune checkpoint inhibitor improved overall survival (OS) for patients with advanced bladder cancer and stable disease following first-line chemotherapy, an interim analysis of a phase III trial found.

Report From the International Society of Urological Pathology (ISUP) Consultation Confe...
https://doi.org/10.1097/PAS.0000000000001453
The American Journal of Surgical Pathology; Warrick JI, Knowles MA et. al.

Feb 24th, 2020 - During the 2019 International Society of Urological Pathology Consultation Conference on Molecular Pathology of Urogenital Cancer, the Working Group on Bladder Cancer presented the current status and made recommendations on the diagnostic use of m...

Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives.
https://doi.org/10.1016/j.euf.2020.01.007
European Urology Focus; Gakis G

Jan 28th, 2020 - Despite an increased use of neoadjuvant and adjuvant chemotherapy, the long-term survival rates after radical cystectomy or trimodal therapy (TMT) for muscle-invasive bladder cancer (MIBC) remain basically unchanged for decades. Detection and effe...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  20,879 results

ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update.
https://doi.org/10.1016/j.jacr.2021.02.011
Journal of the American College of Radiology : JACR; , Allen BC et. al.

May 7th, 2021 - Urothelial cancer is the second most common cancer, and cause of cancer death, related to the genitourinary tract. The goals of surveillance imaging after the treatment of urothelial cancer of the urinary bladder are to detect new or previously un...

The Epidemiology of Bladder Cancer.
https://doi.org/10.1016/j.hoc.2021.02.001
Hematology/oncology Clinics of North America; Mossanen M

May 7th, 2021 - There are many risk factors for bladder cancer. During an initial assessment of a patient with bladder cancer, a careful discussion and history assessment is important. Particular focus should include social history with details regarding occupati...

Molecular Biology of Bladder Cancer: Potential Implications for Therapy.
https://doi.org/10.1016/j.hoc.2021.02.009
Hematology/oncology Clinics of North America; McConkey DJ

May 7th, 2021 - Recently completed studies provided high-resolution descriptions of the molecular biological characteristics of urothelial bladder cancers. Whole transcriptome messenger RNA expression profiling revealed that they can be grouped into basal and lum...

Current Perioperative Therapy for Muscle Invasive Bladder Cancer.
https://doi.org/10.1016/j.hoc.2021.02.002
Hematology/oncology Clinics of North America; Ma J, Black PC

May 7th, 2021 - Radical cystectomy is curative in only approximately 50% of patients with muscle-invasive bladder cancer. Although perioperative radiotherapy has been tested with the intent of improving locoregional disease control, there currently is no role for...

Current Therapy and Emerging Intravesical Agents to Treat Non-Muscle Invasive Bladder C...
https://doi.org/10.1016/j.hoc.2021.02.003
Hematology/oncology Clinics of North America; Bree KK, Brooks NA et. al.

May 7th, 2021 - Transurethral resection of bladder tumor remains the cornerstone of non-muscle invasive bladder cancer management, proper risk stratification, and appropriate selection of adjuvant therapy. A single, postoperative dose of intravesical chemotherapy...

see more →

News  929 results

Arterial Thromboembolism Risk Varies Across Cancer Types, Ages
https://www.medscape.com/viewarticle/949662

Apr 20th, 2021 - Patients with cancer face an increased risk of arterial thromboembolic events, including myocardial infarction (MI) and stroke, and for some that risk appears substantial, according to a new population-based study. For example, the 6-month inciden...

Roche Joins AstraZeneca in Ditching US Bladder Cancer Indication for Immunotherapies
https://www.medscape.com/viewarticle/947021

Mar 8th, 2021 - ZURICH (Reuters) - Roche on Monday joined AstraZeneca in withdrawing cancer immunotherapies from U.S. use for bladder cancer that has already been treated with platinum-based chemotherapy, after follow-up studies failed to meet goals. Basel-based ...

Bladder Cancer Indication Withdrawn for Durvalumab
https://www.medscape.com/viewarticle/946293

Feb 22nd, 2021 - After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be withdrawn in the United States for the immunotherapy durvalumab (Imfinzi), AstraZeneca announced. The withdrawal does n...

Aspirin Linked to Reduced Bladder, Breast Cancer Mortality
https://www.medscape.com/viewarticle/945024

Jan 31st, 2021 - The use of low-dose aspirin among older people shows no effect in reducing the incidence of certain cancer types. However, the treatment — particularly with frequency of at least three times a week — is associated with reductions in mortality in b...

Companies Are Profiting From Health Data—Patients Should Too
https://www.medscape.com/viewarticle/944734

Jan 26th, 2021 - My patient, a woman with metastatic bladder cancer who was about to move to a different part of the country, was perplexed: "Can't you just give me my records on a flash drive?" Unfortunately it wasn't that easy. Forms needed to be routed through ...

see more →

Patient Education  43 results see all →